We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

56 hedge funds and large institutions have $61M invested in abrdn Life Sciences Investors in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 14

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

2% more funds holding

Funds holding: 55 → 56 (+1)

1% more capital invested

Capital invested by funds: $60.1M → $61M (+$895K)

0.59% more ownership

Funds ownership: 14.44% → 15.02% (+0.59%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
56
Holders Change
+1
Holders Change %
+1.82%
% of All Funds
1.28%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
6
Increased
23
Reduced
14
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
+$1.11M
2
Morgan Stanley
Morgan Stanley
New York
+$550K
3
RJA
Raymond James & Associates
Florida
+$542K
4
PAG
Private Advisor Group
New Jersey
+$436K
5
FHA
Flagship Harbor Advisors
Massachusetts
+$419K

Top Sellers

Rank Fund Capital Flow
1
LPL Financial
LPL Financial
California
-$825K
2
WAM
Weiss Asset Management
Massachusetts
-$371K
3
CAN
Claraphi Advisory Network
United States
-$300K
4
MIC
Meridian Investment Counsel
California
-$199K
5
Bank of America
Bank of America
North Carolina
-$127K
Name Holding Trade Value Shares
Change 		Change in
Stake
DA
26
Doliver Advisors
Texas
$281K -$63.8K -3,186 -18%
NSAM
27
North Star Asset Management
Wisconsin
$257K – – –
NEPWA
28
New England Private Wealth Advisors
Massachusetts
$240K +$1.98K +99 +0.8%
IA
29
IFP Advisors
Florida
$236K – – –
QCIG
30
Quad-Cities Investment Group
Iowa
$233K +$242K +12,071 New
Creative Planning
31
Creative Planning
Kansas
$220K -$24.7K -1,234 -10%
UCFA
32
United Capital Financial Advisors
Texas
$206K -$11.8K -588 -5%
BTS
33
BB&T Securities
Virginia
$205K -$20K -1,000 -9%
Cerity Partners
34
Cerity Partners
New York
$192K – – –
PA
35
Parallel Advisors
California
$141K – – –
LNB
36
Ledyard National Bank
$74K +$76.6K +3,825 New
LF
37
Lee Financial
Texas
$67K +$70.1K +3,500 New
SPIA
38
Steward Partners Investment Advisory
New York
$63K -$19.5K -975 -23%
VNA
39
Valley National Advisers
Pennsylvania
$58K – – –
ASN
40
Advisory Services Network
Georgia
$50K +$781 +39 +2%
Citigroup
41
Citigroup
New York
$37K +$801 +40 +2%
PMFA
42
Plante Moran Financial Advisors
Michigan
$32K – – –
NSIM
43
North Star Investment Management
Illinois
$27K +$581 +29 +2%
PNC Financial Services Group
44
PNC Financial Services Group
Pennsylvania
$21K – – –
SIA
45
SeaBridge Investment Advisors
New Jersey
$18K – – –
RE
46
RBC Europe
United Kingdom
$17.5K – – –
SWP
47
Stratos Wealth Partners
Ohio
$15K +$320 +16 +2%
AF
48
Advisornet Financial
Minnesota
$13K +$280 +14 +2%
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$13K +$10.4K +520 +351%
GAM
50
Gemmer Asset Management
California
$12K – – –
1
2
3

HQL Hedge Fund Activity: Q1 2018 in Review

56 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2018, worth a combined $61M — up 1.5% from $60.1M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new HQL positions and 5 closed out — a net gain of 1 holder — while 23 added to existing stakes and 14 trimmed.

The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $1.11M. The largest seller was LPL Financial, cutting an estimated $825K.

  • 56 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2018, up from 55 in Q4 2017.
  • Funds reported $61M of abrdn Life Sciences Investors stock for Q1 2018, up 1.5% quarter-over-quarter.
  • 6 funds opened new abrdn Life Sciences Investors positions in Q1 2018 and 5 closed out, a net change of +1 holder.
  • The largest abrdn Life Sciences Investors buyer in Q1 2018 was Wolverine Asset Management, an estimated $1.11M added.
  • The largest abrdn Life Sciences Investors seller in Q1 2018 was LPL Financial, an estimated $825K sold.

Based on aggregated 13F filings for Q1 2018.